Departments & Organizations
Dr. Bortnichak is global head of the Pharmacoepidemiology and Database Research unit at Merck & Co., Inc. His career in the pharmaceutical industry spans 20 years. Immediately prior to joining Merck, Ed was Vice President, Scientific and Medical Healthcare Relations for Astra Zeneca and, prior to that Scientific Affairs role, he served as the Executive Director of Quantitative Decision Sciences for Astra Zeneca, U.S. Clinical Development. He has also held leadership positions managing Research Integration, Statistics, Epidemiology, Drug Safety and Outcomes Research Departments for Sanofi-Synthelabo, Ciba-Geigy, Berlex Laboratories, Pfizer and Ingenix. Prior to his industry career, he co-directed a community heart health behavior change program in Rhode Island and held a faculty post at Brown University
Ed did his undergraduate studies at the University of Pennsylvania. He holds a Ph.D. in chronic disease epidemiology from the Yale University Graduate School and a Masters of Public Health (M.P.H.) from the Yale University School of Medicine. His post-doctoral work (also at Yale) was in advanced statistical methods, and he currently holds a faculty position as a lecturer in Epidemiology at Yale.
Education & Training
|PhD||Yale University (1981)|